Viewing Study NCT06760650


Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2025-12-24 @ 5:20 PM
Study NCT ID: NCT06760650
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-01-07
First Post: 2024-12-26
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Fluorescein Angiography in Patients With Diabetes and Chronic Kidney Disease
Sponsor: Saint-Joseph University
Organization:

Study Overview

Official Title: Fluorescein-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney Disease
Status: NOT_YET_RECRUITING
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: Fluo-AKI
Brief Summary: Our study hypothesizes that fluorescein exposure in diabetic patients with advanced chronic kidney disease results in deterioration of kidney function. It will therefore aim to evaluate the incidence of acute kidney injury induced by fluorescein in diabetic patients with CKD. The objective is to determine the incidence, severity and risk factors associated with this deterioration to improve the care of this specific population.
Detailed Description: This study will assess the change in serum creatinine in patients with diabetes and advanced chronic kidney disease, after a fluorescein angiography. This is a before and after study that will include 35 patients from the department of ophtalmology over 6 months with a total follow-up for 3 months.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
Tfem-2025-79 OTHER Faculty of Medicine, Saint Joseph University of Beirut View